IGM Biosciences Faces Delisting Concerns
| Field | Detail |
|---|---|
| Company | Igm Biosciences, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
IGM Biosciences might get delisted - big trouble ahead.
AI Summary
IGM Biosciences, Inc. filed an 8-K on June 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported as June 6, 2025. The company, previously known as Palingen, Inc., is incorporated in Delaware and headquartered in Mountain View, California.
Why It Matters
This filing indicates potential issues with IGM Biosciences' compliance with stock exchange listing requirements, which could lead to the company's stock being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can severely impact a company's stock price and liquidity.
Key Numbers
- 001-39045 — SEC File Number (Identifies the company's filing history with the SEC.)
- 77-0349194 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- IGM Biosciences, Inc. (company) — Registrant
- Palingen, Inc. (company) — Former Company Name
- June 6, 2025 (date) — Earliest event reported
- June 11, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Mountain View, California (location) — Principal Executive Offices
FAQ
What specific listing rule or standard has IGM Biosciences failed to satisfy?
The filing does not specify the exact rule or standard that IGM Biosciences has failed to satisfy, only that a notice has been issued.
What is the earliest date associated with the event reported in this 8-K?
The earliest event reported is dated June 6, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on June 11, 2025.
What was IGM Biosciences' former company name?
IGM Biosciences, Inc. was formerly known as Palingen, Inc.
Where are IGM Biosciences' principal executive offices located?
IGM Biosciences, Inc.'s principal executive offices are located at 325 E. Middlefield Road, Mountain View, California.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding IGM Biosciences, Inc..